Neovasc Inc. (NVCN): Price and Financial Metrics
NVCN Stock Summary
- NVCN's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 4.57% of US stocks.
- As for revenue growth, note that NVCN's revenue has grown -79.42% over the past 12 months; that beats the revenue growth of only 1.87% of US companies in our set.
- Neovasc Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -123.57%, greater than the shareholder yield of only 1.68% of stocks in our set.
- Stocks that are quantitatively similar to NVCN, based on their financial statements, market capitalization, and price volatility, are NPTN, VXRT, DSPG, CLSD, and PTN.
- Visit NVCN's SEC page to see the company's official filings. To visit the company's web site, go to www.neovasc.com.
NVCN Stock Price Chart Interactive Chart >
NVCN Price/Volume Stats
|Current price||$0.99||52-week high||$3.88|
|Prev. close||$1.01||52-week low||$0.68|
|Day high||$1.02||Avg. volume||5,591,861|
|50-day MA||$1.39||Dividend yield||N/A|
|200-day MA||$1.65||Market Cap||65.98M|
Neovasc Inc. (NVCN) Company Bio
Neovasc is a specialty medical device company that develops, manufactures and markets products for the cardiovascular marketplace. The Company also sells a line of biological tissue products that are used as components in third-party medical products including transcatheter heart valves. The company was founded in 2000 and is based in Richmond, Canada.
NVCN Latest News Stream
|Loading, please wait...|
NVCN Latest Social Stream
View Full NVCN Social Stream
Latest NVCN News From Around the Web
Below are the latest news stories about Neovasc Inc that investors may wish to consider to help them evaluate NVCN as an investment opportunity.
Neovasc (NVCN) delivered earnings and revenue surprises of 66.67% and -6.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Vancouver, British Columbia and Minneapolis, Minnesota–(Newsfile Corp. – March 11, 2021) – Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (“Neovasc” or the “Company”), today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter Highlights Generated revenue of $514,000 in the quarter and $1.97 million for the full year as… Read More »Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
VANCOUVER and MINNEAPOLIS, March 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), today reported financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter Highlights Generated revenue of $514,000 in the quarter and $1.96 million for the full year as Reducer implants rebounded after declining due to the COVID-19 pandemic.In December, announced the completion of the first Neovasc Reducer™ (“Reducer”) implants in France.Completed a registered direct share offering in December, which raised $6.1 million gross proceeds.Announced the publication of a peer-reviewed article in EuroIntervention, which presented data from the ongoing Reducer-I trial that supported the safety and efficacy of Redu...
NEW YORK, NY / ACCESSWIRE / March 11, 2021 / Neovasc, Inc. (NASDAQ:NVCN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 11, 2021 at 4:30 PM Eastern Time.
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - March 4, 2021) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) will report results for the fourth quarter and fiscal year ended December 31, 2020 after the market close on Thursday, March 11, 2021. Neovasc President and Chief Executive Officer Fred Colen and Chief Financial Officer Chris Clark will host a conference call to review the Company's results at 4:30 pm EST.Interested parties may access the ...
NVCN Price Returns
Continue Researching NVCNWant to do more research on Neovasc Inc's stock and its price? Try the links below:
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!